We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Diagnostic Technology Platform

By HospiMedica staff writers
Posted on 11 Jan 2006
A new biosensor technology platform allows users to assess multiple diagnostic markers quickly and efficiently, facilitating a fast turnaround time in patient point-of-care (POC) testing.

The platform, known as Project Maple, was invented by a team of researchers at the University of Toronto (Canada), headed by Dr. More...
Michael Thompson, professor of analytic chemistry in the department of chemistry and associated member of the Institute for Biomaterials and Biomedical Engineering. The platform, owned by Sensor Chem International Corp., is being acquired by MedMira, Inc. (Halifax, Canada; www.medmira.com), which plans to use the new technology to broaden its product offerings.

The new products and applications resulting from Project Maple will complement the current product portfolio of MedMirwa, which consists of rapid flow-through POC tests for HIV, hepatitis C, and other infectious diseases. The new technology can be easily implemented in clinics, hospitals, and laboratories, according to MedMira.

Facing labor shortages and demand for faster, reliable test results, clinical laboratories are continually looking for increased automation and simplicity. Project Maple's product line will enable fast and easy sample preparation and the ability to provide digital tracking of diagnostic results into electronic patient record systems.

"Project Maples is a ground-breaking technology platform for the diagnostic world, and MedMira is well equipped to bring this new technology to the international market,” observed Dr. Thompson, who is also chairman and co-founder of SensorChem.

MedMira will buy all the outstanding chares of SensorChem for about U.S.$2,066,720. SensorChem will continue to operate as a wholly owned subsidiary of MedMira. MedMira supplies rapid diagnostic solutions to healthcare communities around the world.




Related Links:
MedMira

Gold Member
12-Channel ECG
CM1200B
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Medical Examination & Procedure Light
Vega 80
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Conceptual schematic of MEND in combination with eCPCs for laryngotracheal reconstruction (Gehret, P., Ali Akbari Ghavimi, S., Dumas, A.A. et al.Nature Communications (2026). DOI: 10.1038/s41467-026-73680-2)

Personalized Cartilage Graft Offers New Option for Infants with Severe Airway Narrowing

Severe subglottic stenosis is a narrowing of the airway below the vocal cords and above the trachea. The condition can leave infants dependent on tracheostomy while awaiting reconstructive surgery to enable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.